Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
BRD0539 is stable in human plasma and reversibly inhibits SpCas9
Smiles: CC(C)N(C1=CC=C(F)C=C1F)C(=O)N1C=NN(C2=CC=C(Cl)C=C2Cl)C1=O
Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates
CAS Number: 548470-11-7
InChiKey: DUPAJELXESPTNF-RNEKHSKBSA-N
Dinaciclib - CAS# 779353-01-4 Catalog No.:M10712-10 BRD0539 is stable in humanDinaciclib, also known as SCH727965, is a potent CDK inhibitor with potential antineoplastic activity. Dinaciclib selectively inhibits cyclin dependent kinases CDK1, CDK2, CDK5, and CDK9 activity in vitro with IC(50) values of 1, 1, 3, and 4 nmol L, respectively. Compared with flavopiridol, Dinaciclib exhibits superior activity with an improved therapeutic index. Dinaciclib induced regression of established solid tumors in a range of mouse models
US$ 16.00
US$ 104.95
US$ 17.99
US$ 22.00
US$ 24.99
US$ 84.95